FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

342411000001104: Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16762901000001117 Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58209201000001114 Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) Is a Ranitidine 25mg/mL injection solution 2mL ampule false Inferred relationship Existential restriction modifier
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) Has active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) Has active ingredient Ranitidine false Inferred relationship Existential restriction modifier
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) Is a Zantac true Inferred relationship Existential restriction modifier
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) Is a Ranitidine 50mg/2ml solution for injection ampoules false Inferred relationship Existential restriction modifier
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) Is a Ranitidine 50mg/2ml solution for injection ampoules true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) 5 ampoule Is pack of False Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) 5 ampoule Has AMP True Zantac 50mg/2ml solution for injection ampoules (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start